PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation.

作者: Stephan Kolodziej , Olga N. Kuvardina , Thomas Oellerich , Julia Herglotz , Ingo Backert

DOI: 10.1038/NCOMMS4995

关键词:

摘要: The transcription factor Tal1 is a critical activator or repressor of gene expression in hematopoiesis and leukaemia. mechanism by which differentially influences distinct genes not fully understood. Here we show that interacts with the peptidylarginine deiminase IV (PADI4). We demonstrate PADI4 can act as an epigenetic coactivator through influencing H3R2me2a. At Tal1/PADI4 target IL6ST repressive H3R2me2a mark triggered PRMT6 counteracted PADI4, augments active H3K4me3 thus increases expression. In contrast, at CTCF promoter acts repressor. propose influence on plays role control during lineage differentiation hematopoietic stem/progenitor cells. These results open possibility to pharmacologically

参考文章(70)
R. C. Larson, I. Lavenir, T. A. Larson, R. Baer, A. J. Warren, I. Wadman, K. Nottage, T. H. Rabbitts, Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. The EMBO Journal. ,vol. 15, pp. 1021- 1027 ,(1996) , 10.1002/J.1460-2075.1996.TB00439.X
Xingwei Sui, Kohichiro Tsuji, Yasuhiro Ebihara, Ryuhei Tanaka, Kenji Muraoka, Makoto Yoshida, Kaoru Yamada, Kiyoshi Yasukawa, Tetsuya Taga, Tadamitsu Kishimoto, Tatsutoshi Nakahata, Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34+ cells through glycoprotein (gp) 130 signaling Blood. ,vol. 93, pp. 2525- 2532 ,(1999) , 10.1182/BLOOD.V93.8.2525
F. Facchiano, M. Valtieri, V. Lulli, C. Peschle, L. Vitelli, E. Proietti, G. L. Condorelli, K. Huebner, C. M. Croce, T-Cell-directed TAL-1 Expression Induces T-Cell Malignancies in Transgenic Mice Cancer Research. ,vol. 56, pp. 5113- 5119 ,(1996)
Q. Chen, J.T. Cheng, L.H. Tasi, N. Schneider, G. Buchanan, A. Carroll, W. Crist, B. Ozanne, M.J. Siciliano, R. Baer, The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. The EMBO Journal. ,vol. 9, pp. 415- 424 ,(1990) , 10.1002/J.1460-2075.1990.TB08126.X
M. A. Kelliher, D. C. Seldin, P. Leder, Tal‐1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. The EMBO Journal. ,vol. 15, pp. 5160- 5166 ,(1996) , 10.1002/J.1460-2075.1996.TB00900.X
David S. Hong, Laura S. Angelo, Razelle Kurzrock, Interleukin-6 and its receptor in cancer: implications for translational therapeutics Cancer. ,vol. 110, pp. 1911- 1928 ,(2007) , 10.1002/CNCR.22999
Carmen G Palii, Carolina Perez-Iratxeta, Zizhen Yao, Yi Cao, Fengtao Dai, Jerry Davison, Harold Atkins, David Allan, F Jeffrey Dilworth, Robert Gentleman, Stephen J Tapscott, Marjorie Brand, Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages The EMBO Journal. ,vol. 30, pp. 494- 509 ,(2011) , 10.1038/EMBOJ.2010.342
Simon A. Jones, Jürgen Scheller, Stefan Rose-John, Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling Journal of Clinical Investigation. ,vol. 121, pp. 3375- 3383 ,(2011) , 10.1172/JCI57158
Priyanka Sharma, Saliha Azebi, Patrick England, Tove Christensen, Anné Møller-Larsen, Thor Petersen, Eric Batsché, Christian Muchardt, Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression PLoS Genetics. ,vol. 8, pp. e1002934- ,(2012) , 10.1371/JOURNAL.PGEN.1002934
Xiaotian Chang, Jinxiang Han, Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors Molecular Carcinogenesis. ,vol. 45, pp. 183- 196 ,(2006) , 10.1002/MC.20169